Sean Brynjelsen Net Worth & Insider Trades

Sean Brynjelsen - Chief Executive Officer, Eton Pharmaceuticals, Inc

As of September 23, 2022

What is Sean Brynjelsen's Net Worth?

The current estimated net worth of Eton Pharmaceuticals, Inc's Chief Executive Officer, Sean Brynjelsen, is estimated to be about $32.74M . Sean Brynjelsen owns about 1,064,940 units of Eton Pharmaceuticals, Inc common stock. In the last 4 years at Eton Pharmaceuticals, Inc, Sean Brynjelsen has sold an estimated value of $0 worth.

What is Sean Brynjelsen's Past Insider Trading?

Sean Brynjelsen's largest purchase order was 10,000 units , worth over $79.33K on May 22, 2019. In total, Sean Brynjelsen has made about 11 transactions over 4 years of their time at Eton Pharmaceuticals, Inc. Sean Brynjelsen usually trades in May, August and March, with the busiest year in 2019, 2022 and 2021. The most recent transaction was a purchase order of 10,000 units , worth over $21.04K on September 23, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Sean Brynjelsen's Salary in 2020?

As Chief Executive Officer of Eton Pharmaceuticals, Inc, Sean Brynjelsen has a total base salary of $475,833 . Sean Brynjelsen received compensation valued at about $2,011,293 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of other earnings, plans or compensations of $218,700 , option awards of $1,305,360 , and other compensation of $11,400 .

What is Sean Brynjelsen's' Mailing Address?

  • Mailing address is C/o Eton Pharmaceuticals, Inc. 21925 W Field Pkwy #235 Deer Park IL 60010 IL

Eton Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Sean E. Brynjelsen 2020 $475,833 $218,700 - $1,305,360 $11,400 $2,011,293
Sean E. Brynjelsen 2019 $409,958 $186,500 - $1,338,750 $11,200 $1,946,408
W. Wilson Troutman 2020 $277,083 $108,000 - $509,629 $11,400 $906,112
W. Wilson Troutman 2019 $242,667 $87,500 - $523,260 $11,200 $864,627
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1710340/000149315221009679/formdef14a.htm

What are Eton Pharmaceuticals, Inc's Past Insider Trades?

Eton Pharmaceuticals, Inc's most recent insider trade came on September 23, 2022 by Sean Brynjelsen who bought 10,000 units worth $21.04K . In the last 4 years, insiders at Eton Pharmaceuticals, Inc have sold an estimated value of $20.77M and bought an estimated value of $3.29M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Sean Brynjelsen, Chief Executive Officer,  Opaleye Management Inc,  and Charles Casamento, Director .

Eton Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1